Open Access 01.12.2016 | Erratum
Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group
Erschienen in: Journal of Hematology & Oncology | Ausgabe 1/2016